Mauna Kea Technologies SA (FRA:1MK)
0.0677
+0.0048 (7.63%)
At close: Nov 28, 2025
Mauna Kea Technologies Company Description
Mauna Kea Technologies SA, a medical device company, manufactures and sells medical devices in Europe and internationally.
It offers range of medical devices in gastroenterology, pulmonology, and urology areas. Its product portfolio includes Cellvizio, a real-time in vivo cellular imaging platform which enables physicians to monitor progression of disease over time, assess point-in-time reactions, classify indeterminate areas, and guide surgical interventions.
The company was incorporated in 2000 and is headquartered in Paris, France.
Mauna Kea Technologies SA
| Country | France |
| Founded | 2000 |
| Industry | Electromedical and Electrotherapeutic Apparatus |
| Employees | 65 |
| CEO | Alexandre Loiseau |
Contact Details
Address: 9, rue d'Enghien Paris, 75010 France | |
| Phone | 33 1 48 24 03 45 |
| Website | maunakeatech.com |
Stock Details
| Ticker Symbol | 1MK |
| Exchange | Frankfurt Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Alexandre Loiseau | Chief Executive Officer |
| Come de La Tour du Pin | Chief Financial Officer |
| Nathalie Lecoq | Chief Operating Officer |